EUVIMEDEUVIMED entdecken
Crossref

UDP-GlcUA triggers PKR kinase activity to promote liquid-liquid phase separation of TOP2A and enhances radioimmunotherapy resistance

Hua Yu, Tiezhu Shi, Huiying Chu, Dongwei Xu, Xiaoyong Gong, Lingyun Xiao, Ye Liu, Qiang Xia, Qi Zhou, Yufeng Ding, Guohui Li, Xiongjun Wang

Molecular Cell · 2025-11 · 85 (21) · 3913-3929.e9

DOI: 10.1016/j.molcel.2025.10.011 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Cell, 2025-11. Verfasst von Hua Yu und 11 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Sciences, Guangzhou University, Guangzhou, Guangdong 510006, China. Hauptthemen laut MEDLINE: DNA Topoisomerases, Type II, Carcinoma, Hepatocellular, Poly-ADP-Ribose Binding Proteins, Liver Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: Liaoning Revitalization Talents Program, National Natural Science Foundation of China, Key Technologies Research and Development Program of Guangzhou Municipality.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

To enhance the effectiveness of irradiation (IR) and optimize PD-1/PD-L1 blockade therapy for hepatocellular carcinoma (HCC), we conducted in vivo CRISPR-Cas9 metabolic sublibrary screening, pinpointing UDP-glucose dehydrogenase (UGDH) as a key target. Post-IR, protein kinase R (PKR) translocates to the nucleus. There, elevated UGDH produces UDP-GlcUA, which binds PKR's dsRNA-binding domain (dsRBD). This binding triggers PKR dimerization, autophosphorylation (T451), and activation. Activated PKR then phosphorylates TOP2A at S1467, inducing its liquid-liquid phase separation (LLPS) and enhancing topoisomerase activity, and finally protects tumor cells from IR-induced DNA damage. Disrupting the UDP-GlcUA/PKR complex reduces TOP2A-S1467 phosphorylation, lowers topoisomerase activity, increases cGAS-STING signaling, and improves anti-PD-L1 immunotherapy efficacy. Clinical HCC sample analysis confirmed the relevance of UDP-GlcUA and the phosphorylation of PKR and TOP2A in response to radiation. Critically, blood UDP-GlcUA may serve as a biomarker for PKR/TOP2A axis activation, guiding patient suitability for anti-PD-L1 immunotherapy after IR and enabling personalized treatment strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DNA Topoisomerases, Type IICarcinoma, HepatocellularPoly-ADP-Ribose Binding ProteinsLiver NeoplasmseIF-2 KinaseRadiation ToleranceHumansPhosphorylationAnimalsMiceCell Line, TumorSignal TransductionPhase Separation

Stichwörter der Autor:innen

LLPSPKRTOP2AUGDHliver cancermetabolite

Substanzen

TOP2A protein, humanDNA Topoisomerases, Type IIPoly-ADP-Ribose Binding ProteinseIF-2 KinaseEIF2AK2 protein, human

Autor:innen und Institutionen

  • School of Life Sciences, Guangzhou University, Guangzhou, Guangdong 510006, China.
  • Interdisciplinary Research Center for Biology and Chemistry, Liaoning Normal University, Dalian, Liaoning 116029, China; State Key Laboratory of Molecular Reaction Dynamics, Dalian Institute of Chemical Physics, Chinese…
  • Department of Liver Surgery, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China.
  • Department of General Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China; Department of General Surgery, Ruijin-hainan Hospital, Shanghai Jiao Tong University School of Me…
  • State Key Laboratory of Molecular Reaction Dynamics, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian 116023, China.
  • Department of Liver Surgery, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou 510080, China; Department of General Surgery, Hui Ya Hospital of The First Affiliated Hospital, Sun Yat-sen University, Hui…

Förderung

  • Liaoning Revitalization Talents Program
  • National Natural Science Foundation of China
  • Key Technologies Research and Development Program of Guangzhou Municipality
  • National Key Research and Development Program of China
  • Special Project for Research and Development in Key areas of Guangdong Province

Zitieren

APA

Yu, H., Shi, T., Chu, H., Xu, D., Gong, X., Xiao, L., Liu, Y., Xia, Q., Zhou, Q., Ding, Y., Li, G., & Wang, X. (2025). UDP-GlcUA triggers PKR kinase activity to promote liquid-liquid phase separation of TOP2A and enhances radioimmunotherapy resistance. Molecular Cell, 85(21), 3913-3929.e9. https://doi.org/10.1016/j.molcel.2025.10.011

Vancouver

Yu H, Shi T, Chu H, Xu D, Gong X, Xiao L, et al. UDP-GlcUA triggers PKR kinase activity to promote liquid-liquid phase separation of TOP2A and enhances radioimmunotherapy resistance. Molecular Cell. 2025;85(21):3913-3929.e9. doi:10.1016/j.molcel.2025.10.011

BibTeX
@article{Yu2025,
  author = {Yu, Hua and Shi, Tiezhu and Chu, Huiying and Xu, Dongwei and Gong, Xiaoyong and Xiao, Lingyun and Liu, Ye and Xia, Qiang and Zhou, Qi and Ding, Yufeng and Li, Guohui and Wang, Xiongjun},
  title = {UDP-GlcUA triggers PKR kinase activity to promote liquid-liquid phase separation of TOP2A and enhances radioimmunotherapy resistance},
  journal = {Molecular Cell},
  year = {2025},
  volume = {85},
  number = {21},
  pages = {3913--3929.e9},
  doi = {10.1016/j.molcel.2025.10.011}
}
Kostenlos starten →